cGMP - everything you need to know

michael-muehlegger

Michael Mühlegger

March 1, 2023

The current Good Manufacturing Practice (cGMP) regulations - originated and checked by the FDA - apply to companies operating in pharmaceutical, biotech, or med tech industries. 

They require the latest standards in terms of production, manufacturing, and packaging and thereby ensure pharmaceutical quality meaning quality in biopharmaceutical processing and patient safety as the ultimate goal. The detailed guidelines, importance of cGMP, and how companies can best meet the cGMP regulations, are discussed in the following.

Current good manufacturing practices in the biopharmaceutical industry

Manufacturers in the biopharmaceutical industry are required to comply with cGMP. For good reason: Taking medicines must be safe for patients. The complex regulations affect many different areas involved in the production and manufacturing process, such as facilities, equipment, staff, testing, or documentation. But what are ways to comply with cGMP?

End-to-end solutions based on automated single-use technologies are an auspicious choice for drug substance manufacturers given their many advantages. Their implementation in the manufacturing process promises efficiency, high product quality, cost reduction, and energy savings.

cGMP definition

Current Good Manufacturing Practice, also known as cGMP, are a set of regulations that ensure the quality of pharmaceutical products, medical devices, biotechnology products, food and beverage, and dietary supplements. They therefore apply to all organizations involved in the manufacturing processes of these products.

To be compliant with the cGMP regulations, companies must meet the latest quality standards. These apply to buildings and facilities, equipment, production, process controls, laboratory controls, packaging and labeling, and returned or salvaged drug products.1 

cgmp

What is GMP?

Like the cGMP, Good Manufacturing Practice (GMP) is part of quality assurance and ensures that companies involved in manufacturing, processing, and packaging drugs, medical devices, some sorts of food, and blood follow certain quality and effectiveness standards. Thereby they should eliminate or at least minimize any kind of contamination, mix-ups, or errors guaranteeing that customers purchase effective and safe products. They concern issues such as equipment verification, process validation, record keeping, and process improvements in form of standardization.

GMP guidelines are very general in nature, meaning that the manufacturers decide and interpret themselves how to best implement them in their business. However, they do have the force of law and can in some cases result in fines, recall, seizure, and jail time if failed to comply.

Since those regulations frequently change, the so-called current Good Manufacturing Practice (cGMP) is a more recent version of the GMP requiring companies to use technologies and systems that are up-to-date.2 

cGMP vs GMP: What is the difference?

Seemingly no difference, the timeliness of the regulations results in differences between GMP and cGMP in terms of quality, cost, and standards:

  • Quality: While GMP covers the required standards of an industry, cGMP ensures that a company is following/applying the latest regulations.
  • Cost: Due to additional testing and state-of-the-art technologies, cGMP is more expensive to implement and maintain than GMP.
  • Standards: GMP regulations are the minimum standards required for pharmaceutical, biotech, medtech, and medical devices industries. With cGMP, on the other hand, companies make sure that they are compliant with the most recent rules and regulations applicable to their industry and also that each step was completed using the latest available methods
cgmp-gmp-difference

What is EU GMP Annex 1?

EU GMP Annex 1 is a regulatory guideline that sets standards for manufacturing sterile medicinal products. The guidelines are set by the European Medicines Agency (EMA) and FDA. It focuses on aseptic processing and contamination control to ensure product safety and quality. The annex covers various areas such as facility design, environmental monitoring, personnel training, and process validation. One significant aspect influenced by Annex 1 is the use of single-use assemblies in fluid management processes. It emphasizes the need for a risk-based approach to ensure the integrity and sterility of single-use systems used in closed systems for fluid management. Compliance with GMP Annex 1 is crucial for companies operating in the biopharmaceutical industry to meet regulatory requirements and maintain high-quality standards.

FDA cGMP guidelines

cGMP compliance is monitored by the Food and Drug Administration (FDA). It sets the rules of CFR (Code of Federal Regulation) Title 21 based on the Federal Food, Drug and Cosmetic Act. The parts addressing the cGMP, list the minimum requirements of the production process from start to finish in order to ensure that the drug product has the identity, quality, strength and purity promised.3 

The cGMP guidelines are described in several parts of Title 21 and allow a good understanding of the regulatory process:
21 CFR Part 314: Applications for FDA Approval to Market a New Drug
21 CFR Part 210: cGMP for Manufacturing, Processing, Packing, or Holding of Drugs
21 CFR Part 211: cGMP for Finished Pharmaceuticals
21 CFR Part 212: cGMP for Positron Emission Tomography Drugs
21 CFR Part 600: Biological Products: General

cGMP requirements:

The following three paragraphs will outline 21 CFR Part 210 in which most regulations revolve around requirements for staff, equipment, facilities, and the production process.

1. cGMP requirements of staff

Especially for companies and organizations involved in drug manufacturing and therefore representing a key cGMP requirement, qualified and trained staff is crucial. The personnel must be appropriately qualified and trained and keep up-to-date with the latest training and knowledge relevant to their tasks. 

Current Good Manufacturing Practice (cGMP) regulations: an overview

2. cGMP requirements of facility & equipment

To be compliant with cGMP regulations, pharmaceutical companies’ buildings and production facilities must be properly and thoroughly maintained to ensure safe and effective manufacturing conditions. Similarly, current Good Manufacturing Practices require organizations to have modern equipment that is conscientiously maintained and not outdated at any time. The same applies to the Standard Operating Procedures (SOP).

3. cGMP requirements of processes & products

cGMP recommend that the processes used to manufacture pharmaceutical products involve the latest science and technology. In addition, it is crucial that a master formula is adhered to for each product throughout the manufacturing process without any deviations. 

How is the FDA controlling cGMP compliance?

The FDA’s role is to first promulgate cGMP regulations and guidance documents and then to determine whether the quality of pharmaceutical products comply with those regulations. In doing so, trained FDA assessors and investigators inspect companies around the world to verify that the facilities, where active ingredients and finished pharmaceutical products are manufactured, meet the standards. Inspections follow a standard procedure and are often based on reports or concerns flagged by the public and the industry. If cGMP violations are found, the manufacturer should implement corrective and preventive actions as part of the overall quality management system.

Meeting cGMP regulations with single-use technology

Implementing fully automated single-use technology in the manufacturing process can help companies to follow the regulations given by the FDA and thus improve their cGMP compliance. Manual processes are replaced by automated technologies and thus fulfill important factors for GMP such as reproducibility, standardization and reduced risk.

Furthermore, a single-use system promises safe storing and transporting during laboratory testing, automated documentation processes and effective and reliable staff processes - everything in line with the CFR Title 21.

Preview-datasheet-automated-aseptic-filling-single-use-support

Download Whitepaper

Whitepaper: Automated Aseptic Filling

Read our Whitepaper about Automated Aseptic Filling in Pharmaceutical Manufacturing | Discover why automatic filling solutions are preferable to manual filling. 

cGMP compliance implementation: What it takes

In order to adhere with cGMP compliance, the FDA requires drug manufacturers to meet various standards. The regulations are set out in 21 CFR (Code of federal regulations) and are flexible in their implementation. Companies can decide for themselves how to best apply the different processing methods and testing procedures.

cGMP requirements are:

  • Buildings and facilities in good condition
  • Regularly maintained and calibrated equipment
  • Qualified and well-trained staff
  • Reliable and reproducible processes
  • cGMP certification

Manufacturers can implement the listed requirements by:

  • Developing a strong quality management system
  • Procurement of raw materials of appropriate quality
  • Establishing robust operating procedures
  • Identifying and investing deviations in product quality
  • Maintaining reliable testing laboratories 

Documentation of batch production records and manufacturing processes

One reason why manufacturers often fail to comply with cGMP regulations is an inadequate master manufacturing record and batch record. However, these are crucial for pharmaceutical manufacturing sites as they keep records about the production performance and the quality of a product. According to 21 CFR 11, both records must be stored electronically over a predetermined time. Automated systems can help to streamline such processes by taking over this documentation.

Automated single-use platform systems conduct data such as audit trails, batch reports, performance data, etc. electronically, save it, and communicate with each other, meaning that data is forwarded to the next platform it goes through.  

They replace manual documentation and thereby require fewer staff, reduce mistakes to a minimum, and are more time efficient. GMP are interrelated with Good Documentation Practices (GDP), which offer directives for the creation and compilation of all types of documents necessary to satisfy GMP and other regulatory requirements. This guarantees the dependability, authenticity, and accuracy of data obtained throughout the research, development, manufacturing, and testing of drugs and medical devices. 

cgmp-compliant-documentation

Staff performance & SOPs

To adhere with the cGMP regulations, company employees must follow Standard Operating Procedures (SOP) and be constantly informed of their changes. 

This requires experience and appropriate staff training. Automated single-use solutions help to standardize and simplify these processes. Single-use technology increases the scalability and efficiency of manufacturing and also the security for the personnel, where safe handling of bulk drug substance is key

Fully automated systems also decrease human errors, which can be dangerous and contaminate the quality of the products. This is also one of the core fundamentals of the Good Automated Manufacturing Practice (GAMP), which are guidelines emphasizing that quality should be tested at every stage of the manufacturing process - from raw materials, facility and equipment, to staff training and hygiene. These guidelines offer a dependable framework for pharmaceutical companies to maintain GMP compliance and deliver top-notch products to their end customers.4 

cGMP compliant fluid management solutions

An automated process solution during fluid management, incl. aspetic filling of drug substance, freezing and packaging, help optimize the manufacturing process and comply to cGMP. Thanks to their automated, standardized processes, single-use technologies provide high efficiency, unrestricted scalability and flexibility. 

The safe and controlled processes ensure that the drug substances are of high quality and product losses as well as contamination are minimized. And above all, the possibility of storing data electronically, makes single-use technologies compliant with the 21CFR11.

cGMP compliant process for filling

RoSS.FILL Lab Scale offers unprecedented filling accuracy

Filling & Filtration for Small Volumes (1mL-1000mL)

Single Use Support’s small volume filling systems help laboratories and manufacturers aliquot volumes from 1mL to 1000mL and scale up to 72+ single-use bags.

cgmp compliant single-use technology

Filling & Filtration for Large Volumes (1L-1000L+)

Single Use Support's RoSS.FILL product line for bulk drug substance is a fully automated filling and filtration system for 2D single-use bags from 1L and 50L, 3D single-use bags up to 1000L and for bottles in different sizes.

cGMP compliant process for freezing

Product Photos_RoSS.pFTU Large Scale_transparent_webpage

RoSS.pFTU Large-Scale | Plate Freeze & Thaw

Up to 400L: Our large scale freezing platform system is a plate-based pharmaceutical freeze and thaw unit. The system enables controlled rate freezing and is compatible with single-use bags of all sizes and manufacturers.

Product Photos_RoSS.pFTU Lab Scale_transparent_webpage

RoSS.pFTU Lab-Scale | Plate Freeze & Thaw

1mL-10L: Laboratory freezer, compatible with single use bags of all sizes and manufacturers. Our lab freezer is the perfect solution for studies conducted in labs and, above all, if you want to start a controlled and scalable freezing process.

GMP Annex 1 regulations and single-use technologies

GMP Annex 1 is a regulatory guideline that focuses on manufacturing sterile medicinal products. It addresses aseptic processing and contamination control to ensure product safety and quality. One effective solution to meet Annex 1 requirements is the implementation of single-use technology. By utilizing single-use assemblies, companies can enhance sterility and integrity while minimizing the risk of cross-contamination. Single-use technology offers advantages such as reduced cleaning validation, faster changeovers, and improved operational flexibility. It aligns with the principles of Annex 1 by providing a closed system approach for fluid management, promoting product safety, and simplifying compliance with regulatory guidelines.

Conclusion: What is necessary for cGMP compliant manufacturing?

As single-use systems are constantly improving, there are now more compelling reasons for manufacturers to adopt this technology. Striking arguments are time efficiency in terms of the reduced setup time for the processes as well as the ease of scalability. Moreover, single-use technologies are also proven to be more sustainable compared to traditional stainless steel equipment, as they take less time to clean and decrease the risk of contamination and product loss.

Single Use Support does not only offer individual products, but also provides complete end-to-end processes that can be customized to meet the specific needs of each manufacturer. Automated processes are a safe option for companies aiming to not only comply with GMP, but the most current version of it. They are reproducible and standardized, and thus help to minimize human error and enable the processing of substantial quantities of drug substances within a few hours. 

Read more about cGMP regulations

Annex 1: All you need to know

Annex 1: All you need to know

Annex 1 is a fundamental framework for the production of sterile medicinal goods. This article will provide an overview of the concept, its history, contents, challenges, and perspectives.

Annex 1 and the PUPSIT requirement

Annex 1 and the PUPSIT requirement

Annex 1 and PUPSIT meant significant changes in the pharmaceutical sector. In this article, we will illustrate the focus areas of Annex 1 and will discuss main aspects of PUPSIT.

  1. Current Good Manufacturing Practice (CGMP) Regulations, https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations, Published 01.03.2023
  2. Facts About the Current Good Manufacturing Practices (CGMPs), https://www.fda.gov/drugs/pharmaceutical-quality-resources/facts-about-current-good-manufacturing-practices-cgmps, Published 01.03.2023
  3. The impact of cGMP compliance on consumer confidence in dietary supplement products, https://www.sciencedirect.com/science/article/abs/pii/S0300483X06000345?via%3Dihub, Published 01.03.2023
  4. Adherence to the Current Good Manufacturing Practice (CGMP) Regulations in the 21st Century, https://stap1701en.previ3w.com/PDF/cphi_annual_rep_2016_v6_lo_res.pdf#page=4, Published 01.03.2023
michael-muehlegger

Michael Mühlegger

Senior Director Marketing & Inside Sales

Michael Mühlegger is the Head of Marketing and Inside Sales at Single Use Support. He has 10+ years experience in the fields of marketing, inside sales, communications, content management, and creative production. With a keen understanding of market dynamics and customer behavior, Michael has successfully implemented innovative marketing strategies to drive business growth and enhance brand visibility.

He has a strong background in content management, with a focus on life sciences and biopharma trends, and is adept at creating compelling content across multiple platforms to engage audiences and effectively communicate brand messages.

 

More from Michael Mühlegger

News

Ania W. Payne, PhD Appointed New Chief Strategy and Marketing Officer of Single Use Support

Single Use Support Announces Ania Payne as new Chief Strategy and Marketing Officer further Strengthening the Leadership Team

michael-muehlegger

Michael Mühlegger

April 17, 2025

News

Darren Verlenden new CEO of Single Use Support

Darren Verlenden is the new CEO of Single Use Support and will work alongside Managing Director Christian Praxmarer. Further additions to Single Use Support’s top management set the course for global expansion.

michael-muehlegger

Michael Mühlegger

December 16, 2024

Read more about Biopharma

Biopharma

Annex 1: All you need to know

Annex 1 is a fundamental framework for the production of sterile medicinal goods. This article will provide an overview of the concept, its history, contents, challenges, and perspectives.

michael-muehlegger

Michael Mühlegger

March 20, 2024

Biopharma

Top 7 pharmaceutical CDMOs in 2024

Progress in the pharmaceutical industry is significantly driven by CDMOs, collaborating with pharma companies. In this article, we will put 7 outstanding CDMOs in the spotlight.

michael-muehlegger

Michael Mühlegger

March 12, 2024

Biopharma

CMO vs. CDMO: What are the differences?

Both CMOs and CDMOs are frequently relied on partners in the pharmaceutical industry. But what sets them apart, where are their strengths, and what do they offer?

michael-muehlegger

Michael Mühlegger

March 12, 2024

Biopharma

Start Pharma 4.0: Examples to Advance Ultra-Cold Storage of Drug Substances

Innovative manufacturers are striving for operational excellence in as many areas of bioprocessing as possible. In return,a standardized and fully automated processes contribute to cost efficiency, patient safety, and sustainability in biomanufacturing. 

Alexander Fuchs | Single Use Support

Alexander Fuchs

September 4, 2023